DE69739670D1 - Thiazolinsäure-Derivate - Google Patents

Thiazolinsäure-Derivate

Info

Publication number
DE69739670D1
DE69739670D1 DE69739670T DE69739670T DE69739670D1 DE 69739670 D1 DE69739670 D1 DE 69739670D1 DE 69739670 T DE69739670 T DE 69739670T DE 69739670 T DE69739670 T DE 69739670T DE 69739670 D1 DE69739670 D1 DE 69739670D1
Authority
DE
Germany
Prior art keywords
derivatives
thiazolinsäure
thiazoline
chelators
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69739670T
Other languages
English (en)
Inventor
Raymond J Bergeron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Application granted granted Critical
Publication of DE69739670D1 publication Critical patent/DE69739670D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69739670T 1996-03-29 1997-03-31 Thiazolinsäure-Derivate Expired - Fee Related DE69739670D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/624,289 US5840739A (en) 1992-11-16 1996-03-29 Thiazoline acid derivatives

Publications (1)

Publication Number Publication Date
DE69739670D1 true DE69739670D1 (de) 2009-12-31

Family

ID=24501405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69739670T Expired - Fee Related DE69739670D1 (de) 1996-03-29 1997-03-31 Thiazolinsäure-Derivate

Country Status (13)

Country Link
US (1) US5840739A (de)
EP (3) EP1380577B1 (de)
JP (2) JP3800559B2 (de)
KR (1) KR20000005100A (de)
AT (1) ATE449088T1 (de)
AU (1) AU715889B2 (de)
BR (1) BR9708460A (de)
CA (1) CA2250243C (de)
DE (1) DE69739670D1 (de)
NO (1) NO315608B1 (de)
NZ (2) NZ509967A (de)
PL (1) PL329172A1 (de)
WO (1) WO1997036885A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
TR200002256T2 (tr) 1998-02-04 2001-03-21 University Of Florida Research Foundation, Inc. Demir celatlama tedavisinde N,N' -BIS(2-Hidroksibenzil) etilendiamin-N, N'diasetik asit içeren farmasötikler.
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) * 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
EP1488791A3 (de) * 1998-09-21 2005-04-06 University Of Florida Research Foundation, Inc. Mittel gegen malaria
CA2344913A1 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
WO2001045696A1 (en) 1999-12-21 2001-06-28 University Of Florida Research Foundation, Inc. N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy
US6689788B1 (en) * 2000-08-25 2004-02-10 University Of Florida Method and composition for treatment of inflammatory bowel disease
US6875883B2 (en) 2002-05-15 2005-04-05 Genzyme Corporation Synthesis of benzonitriles from substituted benzaldehyde
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
AU2006232929B9 (en) 2005-04-04 2009-12-17 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
EP2778234B1 (de) 2005-05-31 2017-09-27 Promega Corporation Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden
WO2008115433A1 (en) * 2007-03-15 2008-09-25 University Of Florida Desferrithiocin polyether analogues
WO2010021686A1 (en) 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
CA2768041A1 (en) * 2009-07-27 2011-02-10 Ferrokin Biosciences, Inc. Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
ES2761200T3 (es) 2011-12-16 2020-05-19 Univ Florida Usos de análogos de 4'-desferritiocina
AU2014352780A1 (en) 2013-11-22 2016-06-09 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3288557A4 (de) 2015-04-27 2018-11-07 University of Florida Research Foundation, Inc. Metabolisch programmierte metallchelatoren und verwendungen davon
EP3802524A1 (de) 2018-05-29 2021-04-14 Cersci Therapeutics, Inc. Verbindungen zur schmerzbehandlung, diese enthaltende zusammensetzungen und verfahren zu ihrer verwendung
WO2020231496A1 (en) 2019-05-10 2020-11-19 Cersci Therapeutics, Inc. Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137529A (en) * 1967-05-04 1968-12-27 Wyeth John & Brother Ltd Thiazole compositions
CY800A (en) * 1968-04-09 1976-12-01 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
DE3170401D1 (en) * 1980-07-28 1985-06-13 Ciba Geigy Ag Triazoline derivatives and processes for their preparation
US5393777A (en) * 1990-11-15 1995-02-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Deferration using anguibactin siderophore
WO1994011367A1 (en) * 1992-11-16 1994-05-26 University Of Florida Research Foundation Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives

Also Published As

Publication number Publication date
WO1997036885A1 (en) 1997-10-09
EP2096112A2 (de) 2009-09-02
CA2250243A1 (en) 1997-10-09
ATE449088T1 (de) 2009-12-15
EP0900209A4 (de) 2001-09-19
EP1380577A1 (de) 2004-01-14
JP3800559B2 (ja) 2006-07-26
JP2006152004A (ja) 2006-06-15
BR9708460A (pt) 2000-01-04
EP0900209A1 (de) 1999-03-10
NO984508D0 (no) 1998-09-28
EP1380577B1 (de) 2009-11-18
EP2096112A3 (de) 2009-09-09
NO984508L (no) 1998-11-23
PL329172A1 (en) 1999-03-15
AU715889B2 (en) 2000-02-10
NZ509967A (en) 2005-06-24
US5840739A (en) 1998-11-24
NZ332049A (en) 2001-04-27
NO315608B1 (no) 2003-09-29
AU2541097A (en) 1997-10-22
KR20000005100A (ko) 2000-01-25
JP2000505086A (ja) 2000-04-25
CA2250243C (en) 2002-10-08

Similar Documents

Publication Publication Date Title
DE69739670D1 (de) Thiazolinsäure-Derivate
DE69727218D1 (de) Einschluss komplexe von aryl-heterokyhlishe salzen
DE69232665D1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
ATE264313T1 (de) Substituierte oxazole und thiazole derivate als hppar-gamma und hppar-alpha aktivatore
NO940789L (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
FI963158A0 (fi) Raskas korkealämpötilainen puristinlaite
FI935524A (fi) Diskontinuerlig CDMA-mottagning
DE3867572D1 (de) Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.
ES2179587T3 (es) Utilizacion de betainas como agentes antitranspirantes.
FI900041A (fi) Substituerade indol-, benzofuran- och benzotiopenderivat saosom 5-lipoxigenasinhibitorer,
DE69501980D1 (de) Temperaturstabilisierte Stromquelle
DE9411754U1 (de) Laser-Ahle zur Behandlung der Osteochondritis deformans
DE59608306D1 (de) Schaltung zur Stromversorgung mehrerer Leistungsverstärker
DK0490634T3 (da) Quinoliniumsaltmellemprodukter
DE69401967D1 (de) Abspaltbare Hydroxycarbonsäuren
DE69125089D1 (de) Stromquelle
DE69429080D1 (de) Konstantstromquelle
FI960371A (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina
PT1098871E (pt) Derivados de ester fenilico de alfa-aminoacidos
ATA12597A (de) Vorrichtung zum kontrollierten abkühlen von heissbrikettiertem direktreduziertem eisenschwamm
KR950019506U (ko) 교환 팰리트의 유압원 공급장치
KR940023802U (ko) 전력용 트랜지스터의 방열장치
KR960025800U (ko) 전원공급장치의 초기 구동 제어 회로
ITMI931178A0 (it) Procedimento per il raffreddamento rapido o il riscaldamento di pezzi
SE9000313D0 (sv) Powerdrive

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee